Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-29 Perl Jessica SVP, General Counsel, Corp Sec Grant or award +104,282 165,286
2026-03-05 Perl Jessica SVP, General Counsel, Corp Sec Shares withheld for taxes −6,465 $8.44 $55K 61,004
2026-03-03 Perl Jessica SVP, General Counsel, Corp Sec Grant or award · Employee Stock Option (Right to buy) +46,702 142,647
2026-02-09 Perl Jessica SVP, General Counsel, Corp Sec Shares withheld for taxes −918 $11.03 $10K 67,469
2025-03-06 Perl Jessica SVP, General Counsel, Corp Sec Grant or award +62,500 68,387
2025-03-06 Perl Jessica SVP, General Counsel, Corp Sec Grant or award · Employee Stock Options (Right to Buy) +62,500 95,945
2025-02-09 Perl Jessica SVP, General Counsel, Corp Sec Shares withheld for taxes −918 $10.00 $9K 5,887

Page 1 of 1 · 7 trades